Home » Topics » BioWorld Science

BioWorld Science
RSS

Vyndaqel approved in Japan for transthyretin amyloid cardiomyopathy

March 26, 2019

Japan first to approve Skyrizi for psoriasis indications

March 26, 2019

Knockout model highlights role of RasD2 in metabolism

March 26, 2019

Japanese MHLW approves Kymriah and related therapies Treakisym and Actemra

March 26, 2019

AQP5 gene polymorphism prolongs survival of patients with sepsis

March 26, 2019

Transgene and BioInvent extend multifunctional oncolytic virus collaboration

March 26, 2019

Vaccibody reports phase IIa data on VB10.16 immunotherapy for CIN 2/3

March 26, 2019

Phase II trial of lurbinectedin in relapsed SCLC meets primary endpoint

March 26, 2019

European phase III ARTEMIS study of AR-101 meets primary endpoint

March 26, 2019

Smyraf approved in Japan to treat rheumatoid arthritis

March 26, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...